Clinical Trial Update: A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update reporting the safety and effectiveness of telaprevir in chronic genotype 1 hepatitis C patients who failed prior standard treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: Tibotec BVBA | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2011-08-11